Back
Allurion Technologies Vs. Perspective Therapeutics Industry Stock Comparison
Sell
6
ALUR
Allurion Technologies
Last Price:
1.28
Seasonality Move:
--
Sell
33
CATX
Perspective Therapeutics
Last Price:
10.27
Seasonality Move:
5.43%
Sell
6
Allurion Technologies (ALUR)
is a Sell
Is Allurion Technologies a Buy, Sell or Hold?
- The current Allurion Technologies [ALUR] share price is $1.26. The Score for ALUR is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- ALUR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $10.49. The Score for CATX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALUR Stock Price Chart
What is Allurion Technologies's stock price today?
-
The Allurion Technologies share price today is $1.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALUR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $10.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ALUR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 44.83 | Sell |
Chaikin Money Flow: | 706074 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.11 - 1.83) | Sell |
Bollinger Bands (100): | (1.53 - 2.69) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.13 | Sell |
Relative Strength Index (14 RSI): | 41.68 | Sell |
Chaikin Money Flow: | -837364 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.23 - 13.59) | Sell |
Bollinger Bands (100): | (10.03 - 15.81) | Sell |
ALUR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Sell |
20-day SMA: | 1.46 | Sell |
50-day SMA: | 1.7 | Sell |
200-day SMA: | 3.03 | Sell |
8-day EMA: | 1.38 | Sell |
20-day EMA: | 1.49 | Sell |
50-day EMA: | 1.71 | Sell |
200-day EMA: | 2.93 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.12 | Buy |
20-day SMA: | 11.4 | Sell |
50-day SMA: | 14.27 | Sell |
200-day SMA: | 8.31 | Buy |
8-day EMA: | 10.47 | Buy |
20-day EMA: | 11.4 | Sell |
50-day EMA: | 12.7 | Sell |
200-day EMA: | 9.92 | Buy |
Allurion Technologies Earnings Growth & ALUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.07 per share, an increase this year of $3.23 per share, and an increase next year of $0.41 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Allurion Technologies Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |